(PharmaNewsWire.Com, May 20, 2017 ) The report titled "Global Glaucoma Treatment Market: Trends and Opportunities (2015 Edition)" analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Glaucoma treatment market. The report elucidates facts on the glaucoma treatment market as supplemented by the latest available statistics. It also profiles and analyzes the leading four companies operating in this industry with latest data and a brief overview of their business and financial performance along with a brief discussion of their future business strategies. The report gives valuable insight into technology used in glaucoma treatment market, its demand in various geographies. In the report, we also try to study the growth pattern in the prescriptions and revenue earned by the glaucoma treatment companies and the latest trends concerning glaucoma treatment market. Most importantly, we have analyzed the current market size and project future market size of the overall glaucoma treatment market for the years to come.
The global Glaucoma market has been growing rapidly since the past several years mainly due to innovation such as introduction of IOPtiMa, OTP-TX, anti-VEGF therapy, photodynamic therapy (PDT) laser photocoagulation, Rhopressa, latanoprost and Vesneo. Among the several varieties of drugs and surgeries available in the market, the demand for drugs such as Prostaglandins which includes Trabatan, Lumbigan are the highest due to its high efficiency in treating glaucoma. Vesneo has shown a superior intraocular pressure reduction effect on beta-blocker timolol, the most widely used comparator in registration trials for glaucoma, in two phase 3 studies.
Globally, the major factors contributing to the growth of Glaucoma treatment market is the higher number of glaucoma patients from the U.S, Europe and Japan. Novel therapies for glaucoma are constantly being investigated by research and development teams of various pharmaceutical companies, at different stages. It can be predicted that novel therapies that work in conjunction with current drugs, such as Prostaglandins, will likely be increasingly common in the near future.
Growth of the Glaucoma treatment market could also be attributed to North America where the number of patients suffering from glaucoma is the highest among the rest of the U.S and also from emerging markets such as France and Singapore driven by rapid increase of old age population. Moreover, the Asian market is expected to become a huge potential market for glaucoma surgery devices in the foreseeable future, as it is expected to grow at comparatively the fastest among all other regions. It is estimated that by 2020, 11 million individuals will have vision loss due to glaucoma.
Glaucoma market is seen as a diversifying risk to other lines of ophthalmic treatment business and is attracting more and more revenue. Glaucoma treatment companies are launching new technologies and adopting new strategies in the industry and making significant investments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
